20/01/2021 10:39 am Welcome to isteroids.com - BLOG

Friday 30, Jul 2010

  Heart treatment drug may be useful for preeclampsia

Posted By
Pin it Share on Tumblr

Heart treatment drug may be useful for preeclampsiaExpecting mothers with severe preeclampsia can benefit from a drug that is presently used for treating patients afflicted with complications of the heart.

Digibind, the drug, is presently under the evaluation stage in the hands of researchers at the University of Texas Medical Branch at Galveston.

Dr. Nicole Ruddock, the study’s principal investigator and an instructor in UTMB’s Department of Obstetrics and Gynecology, remarked that this study has significant implications to treat preeclampsia, particularly when there are no presently available options for providing relief to patients with the complication.

Friday 09, Jul 2010

  Potential drug offers treatment for life endangering disorder

Posted By
Pin it Share on Tumblr

Potential drug offers treatment for life endangering disorderDigibind, a drug presently recommended and used for treating patients afflicted with heart diseases, can be used to delay delivery in expectant mothers with severe preeclampsia. Efficacy of the drug for this purpose is presently under evaluation by researchers at the University of Texas Medical Branch at Galveston.

It is considered that if the evaluation is successful, hundreds of women who are suffering from this life endangering disorder will be relieved.

With no available treatment option at the present, this study is truly groundbreaking as per Dr. Nicole Ruddock, the study’s principal investigator and an instructor in UTMB’s Department of Obstetrics and Gynecology.

Monday 26, Apr 2010

  Old drug identified as prospective preeclampsia cure

Posted By
Pin it Share on Tumblr

old-drug-identified-as-prospective-preeclampsia-cureResearchers at the University of Texas Medical Branch at Galveston are presently evaluating if a drug already available to patients suffering from heart diseases could be used for delaying delivery in expectant mothers with severe preeclampsia. If successful, the groundbreaking study will offer hope to hundred of thousands of women experiencing this life-endangering disorder.

Digibind, the drug, has been prescribed for more than twenty years to patients overdosing on a specific heart medication but is not presently approved for treating preeclampsia, which is the most common and dangerous pregnancy complication affecting as many as eight in every hundred pregnant women.

Dr. George Saade, chief of maternal–fetal medicine at UTMB said that this study is important to protect the mother while allowing the baby to grow and develop without delivering early.

Tuesday 22, Dec 2009

  New drug offers hope for pre-eclampsia treatment

Posted By
Pin it Share on Tumblr

New drug offers hope for pre-eclampsia treatmentEfforts are being made by researchers at the University of Texas Medical Branch at Galveston to find out if the drug, Digibind, presently used by heart patients can be used for delaying delivery in expectant mothers with severe preeclampsia.

If these efforts are met with success, this would indeed be a groundbreaking study offering hopes to thousands of women who are affected by this life-threatening disorder.

Dr. Nicole Ruddock, the study’s principal investigator and an instructor in UTMB’s Department of Obstetrics and Gynecology, said that this study is truly groundbreaking as there is no treatment for preeclampsia presently.